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A total of 50 patients were enrolled in the study, and MRI brain with MR spectroscopy was done. Out 
of these, 35 were HIV positive patients (cases). 15 patients with HIV negative status who also 
underwent MRI for unrelated pathologies were enrolled as controls. They also underwent MRI brain 
with MR spectroscopy. Tuberculosis was the most common neurologic disease found in the HIV 
positive group, consisting of 9 patients. Two patients had healed granulomas. Seven of these patients 
had tuberculous meningitis amongst which a further 2 had vasculitic infarcts. Another two in this 
group had tuberculomas. Prominent lipid lactate peaks on the spectra obtained from the lesions 
confirmed the diagnosis of tuberculoma. PML was seen in 6 patients. NAA/Cr was found to be 
reduced in all the patients, and in fact the value was further reduced compared to the HIV positive 
group as a whole. Raised choline and myoInositol peaks were also found in all the patients. 
Toxoplasmosis was seen in 4 patients. MR Spectroscopy showed lipid – lactate peaks confirming the 
diagnosis. A single patient with brain abscess was seen where also the spectroscopic data from the 
lesion confirmed the diagnosis with a lactate peak as well as amino acid resonances at characteristic 
locations. 2 patients had HIV encephalopathy on the imaging study. Their spectra also revealed 
lowered NAA peaks along with raised choline peaks. 2 patients with cryptococcosis showed 
characteristic imaging finding of enlarged Virchow Robin (perivascular) spaces. They revealed 
elevated choline peaks in addition to reduced NAA. No trehalose peaks were identified. MR 
Spectroscopy was also done in 4 patients of vascular thrombosis, two arterial and two venous, where 
the MR Spectroscopic findings were not specific. In 7 patients no focal lesions could be identified on 
conventional MRI sequences however on MR spectroscopic analysis NAA was found to be reduced in 
comparison to the controls. The values of NAA/Cr were determined after duly processing the 
spectroscopic data from both cases and controls. Each group (Cases and controls) were divided on the 
basis of age into two age groups: Lesser than or equal to 40 years, and greater than 40 years. In all 
three groups the values of the mean NAA/Cr ratio was significantly (p-value less than 0.05) reduced 
in comparison to controls. An ancillary finding was the reduction of NAA/Cr further in cases of PML. 
Combined use of both the conventional and advanced MRI sequences is advisable as spectroscopy 
helps in confirming the diagnosis of opportunistic infection of the CNS in HIV positive patients. 
NAA/Cr ratio is reduced in HIV positive patients and is a marker for HIV infection of the brain even 
in the absence of imaging findings of HIV encephalopathy or when the patient is symptomatic due to 
neurologic disease of other etiologies. 
 
 
INTRODUCTION 
 
 
The Human Immunodeficiency Virus (HIV) is the retrovirus responsible for AIDS. There are two 
subtypes of HIV, HIV-1 and HIV-2. HIV-1 is responsible for the majority of the AIDS cases 
throughout the world, whereas HIV-2 is rarely to be found outside West Africa
1
. 
On June 5, 1981, the Morbidity and Mortality Weekly Report (MMWR), published by the Centers for 
Disease Control and Prevention (CDC), reported Pneumocystis pneumonia in 5 homosexual men. It 
documented for the first time in history what became known as acquired immunodeficiency syndrome 
(AIDS). Within a month, additional diagnoses of opportunistic infections in homosexual men from 
New York City and California were reported. These articles were harbingers for what became one of 
history‘s worst pandemics, with more than 60 million infections, more than 30 million deaths, and 30 
years later, with no definitive cure
1
. 
The Human Immunodeficiency Virus (HIV) is neurovirulent
2
, with up to half of all patients with HIV 
exhibiting neurologic disease, in spite of the establishment of effective antiretroviral therapy
3
. Thus it 
is a major public health problem. 
The study of Central Nervous System disease in HIV infection (CNS-D) in HIV infection is 
complicated by the fact that in addition to the direct effects of HIV on the brain, multiple other disease 
processes including opportunistic infection, neoplasm and immune phenomena contribute 
significantly to the disease burden, all with overlapping imaging features
4,5
. It is significant to note 
that the latest figures for adult prevalence of HIV infection in India from NACO (National AIDS 
control Organization) available are 0.31%. India has the third largest population of people living with 
HIV/AIDS in the world. While the effect of opportunistic infections have reduced since the advent of 
HAART (Highly active antiretroviral therapy), as well as adequate chemoprophylaxis against 
opportunistic infections, given the proportion of patients with HIV who have neurologic disease, the 
morbidity of HIV related brain injury thus remains an important health problem. 
MRI is a more sensitive tool in the workup of HIV positive patients with CNS-D. It helps in the 
diagnosis of specific disease, monitoring of effects of therapy, to guide stereotactic biopsy if required, 
and also to prognosticate cases
5,6
. Although MR imaging is currently the most sensitive imaging 
modality in depicting brain alterations in HIV positive individuals, conventional MR sequences may 
not be able to demonstrate any alterations in the early stages of HIV infection
7
. Of the advanced 
neuroimaging modalities, Magnetic resonance spectroscopy is especially useful as it non-invasively 
provides essential information for understanding the underlying causes of CNS injury in the HIV-
infected patient. By quantifying the surrogate markers of N-acetylaspartate (NAA), creatine (Cr), 
choline (Cho), lactate and myo-inositol (mI), MRS offers insight into the neuronal integrity, cell 
membrane synthesis and turnover, macrophage infiltration, inflammation status, and levels of 
microglial activation and gliosis within the sampled CNS tissue
8
. Many studies have also shown 
metabolite abnormalities early in the pathogenesis of HIV infection, earlier than detectable with 
conventional MR sequences
8
. 
HIV encephalopathy is the most common neurologic complication of HIV infection
7,9
. The most 
common opportunistic infections include Toxoplasmosis, Cryptococcosis, PML, Mycobacterial 
infection, CMV and pyogenic infection
10
. Neoplastic diseases associated with HIV infection include 
Primary CNS lymphoma and metastatic 
Kaposi‘s Sarcoma9. Non-infective and non-neoplastic neurologic complications of 
HIV infections include demyelinating disorders, vascular disorders, Parkinson‘s disease, and 
spontaneous subdural bleeding
11
. 
 
REVIEW OF LITERATURE 
 
1.  HISTORY 
 
In view of the growing importance and near universal applicability of MRI in the practice of 
medicine, Paul Lauterbur of the University of Illinois at Urbana-Champaign and Sir Peter Mansfield 
of the University of Nottingham were awarded the 2003 Nobel Prize in Physiology or Medicine for 
their "discoveries concerning magnetic resonance imaging". The Nobel citation noted Lauterbur's 
insight of using magnetic field gradients to determine spatial localization, a breakthrough discovery 
that allowed rapid acquisition of 2D images. Mansfield was credited with introducing the 
mathematical formalism and developing techniques for efficient gradient utilization and fast imaging. 
 
In the 1950s, Herman Carr reported on the creation of a one-dimensional MR image
12
. Paul Lauterbur 
expanded on Carr's technique and developed a way to generate the first MRI images, in 2D and 3D, 
using gradients. In 1973, Lauterbur published the first nuclear magnetic resonance image and the first 
cross-sectional image of a living mouse was published in January 1974. Nuclear magnetic resonance 
imaging is a relatively new technology first developed at the University of Nottingham, England. 
Peter Mansfield, a physicist and professor at the university, then developed a mathematical technique 
that would allow scans to take seconds rather than hours and produce clearer images than Lauterbur 
had. 
 
In a 1971 paper in the journal  Science
13
, Dr. Raymond Damadian, an  Armenian- American 
physician, scientist, and professor at the Downstate Medical Center  State  University of New York, 
was responsible for one of the first reported clinical uses of the MR Scanning. He reported that  
tumors and normal tissue can be distinguished in vivo by  nuclear magnetic resonance ("NMR"). He 
suggested that these differences could be used to diagnose  cancer, though later research would find 
that these differences, while real, are too variable for diagnostic purposes. Damadian's initial methods 
were flawed for practical use, relying on a point-by-point scan of the entire body and using relaxation 
rates, which turned out to not be an effective indicator of cancerous tissue. 
 
While researching the analytical properties of magnetic resonance, Damadian was responsible for the 
creation of the world's first magnetic resonance imaging machine in 1972. He filed the first patent for 
an MRI machine, on March 17, 1972, which was later issued to him on February 5, 1974. As the  
National Science Foundation notes, "The patent included the idea of using NMR to 'scan' the human 
body to locate cancerous tissue. However, it did not describe a method for generating pictures from 
such a scan or precisely how such a scan might be done‖. Damadian along with Larry Minkoff and 
Michael Goldsmith subsequently went on to perform the first MRI body scan of a human being on 
July 3, 1977. These studies performed on humans were published in 1977. In recording the history of 
MRI, Mattson and Simon (1996) credit Damadian with describing the concept of whole-body NMR 
scanning, as well as discovering the NMR tissue relaxation differences that made this feasible Nuclear 
magnetic resonance (NMR) spectroscopy in the solid and liquid states were first described 
independently by Felix Bloch and Edward Mills Purcell independently in 1946 and they shared the 
Nobel Prize for their discovery in 1952. It is generally known and has been used extensively as an 
analytical method in chemistry to identify molecules and to determine their biophysical 
characteristics. The clinical use of in vivo magnetic resonance spectroscopy (MRS) has been limited 
for a long time, mainly due to its low sensitivity. However, with the advent of clinical MR systems 
with higher magnetic field strengths, the development of better coils, and the design of optimized 
radio-frequency pulses, sensitivity has been considerably improved. Therefore, in vivo MRS has 
become a technique that is routinely used more and more in clinical radiologic practice
14
. There are 
about 20,000 metabolites in the human body
15
. MRS is an ideal technique to measure changes in 
metabolite levels non-invasively, and thus the technique is very suitable in the diagnostics of 
metabolic disorders. However, it should be noted that only small metabolites with sufficiently high 
concentration can be observed by MRS. General Pattern changes in combination with other clinical 
and biochemical information may help to find the correct diagnosis. As time passes and clinical 
experience with MRS increases, a wider range of disorders can be identified with pattern changes in 
MRS spectra. 
 
2.  MRI SEQUENCES 
 
T1-weighted MRI 
 
T1-weighted scans are a standard basic scan, in particular differentiating fat from water - with water 
darker and fat brighter use a gradient echo (GRE) sequence, with short TE and short TR. This is one of 
the basic types of MR contrast and is a commonly run clinical scan. The T1 weighting can be 
increased (improving contrast) with the use of an inversion pulse as in an MP-RAGE sequence. Due 
to the short repetition time (TR) this scan can be run very fast allowing the collection of high 
resolution 3D datasets. A T1 shortening gadolinium contrast agent is also commonly used, with a T1 
scan being collected before and after administration of contrast agent to compare the difference. In the 
brain T1-weighted scans provide good gray matter/white matter contrast; in other words, T1-weighted 
images highlight fat deposition. 
 
T2-weighted MRI 
 
T2-weighted scans are another basic type. Like the T1-weighted scan, fat is differentiated from water - 
but in this case fat shows darker, and water lighter. For example, in the case of cerebral and spinal 
study, the CSF (cerebrospinal fluid) will be lighter in T2-weighted images. These scans are therefore 
particularly well suited to imaging edema, with long TE and long TR. Because the  spin echo sequence 
isless susceptible to inhomogeneities in the magnetic field, these images have long been a clinical 
workhorse. 
T*2-weighted MRI scans use a gradient echo (GRE) sequence, with long TE and long TR. The gradient 
echo sequence used does not have the extra refocusing pulse used in spin echo so it is subject to 
additional losses above the normal T2 decay (referred to as T2′), these taken together are called T2*. 
This also makes it more prone to susceptibility losses at air and tissue boundaries, but can increase 
contrast for certain types of tissue, such as venous blood. 
 
Proton density weighted MRI 
 
Spi density, also called proton density, weighted scans try to have no contrast from either T2 or T1 
decay, the only signal change coming from differences in the amount of available spins (hydrogen 
nuclei in water). It uses a spin echo or sometimes a gradient echo sequence, with short TE and long TR. 
 
Diffusion Weighted Imaging: 
 
Diffusion imaging (DWI) is a modification of regular MRI techniques, and is an approach which 
utilizes the measurement of Brownian motion of molecules. Regular MRI acquisition utilizes the 
behavior of protons in water to generate contrast between clinically relevant features of a particular 
subject. The versatile nature of MRI is due to this capability of producing contrast, called weighting. 
In a typical T1-weighted image, water molecules in a sample are excited with the imposition of a 
strong magnetic field. This causes many of the protons in water molecules to 
Process simultaneously, producing signals in MRI. In T2-weighted images, contrast is produced by 
measuring the loss of coherence or synchrony between the water protons. When water is in an 
environment where it can freely tumble, relaxation tends to take longer. In certain clinical situations, 
this can generate contrast between an area of pathology and the surrounding healthy tissue. 
In diffusion-weighted images, instead of a homogeneous magnetic field, the homogeneity is varied 
linearly by a pulsed field gradient. Since precession is proportional to the magnet strength, the protons 
begin to process at different rates, resulting in dispersion of the phase and signal loss. Another 
gradient pulse is applied in the same direction but with opposite magnitude to refocus or rephrase the 
spins. The refocusing will not be perfect for protons that have moved during the time interval between 
the pulses, and the signal measured by the MRI machine is reduced. This reduction in signal due to 
the application of the pulse gradient can be related to the amount of diffusion that is occurring through 
the following equation: 
 
 
 
 
 
where S0 is the signal intensity without the diffusion weighting, S is the signal with the gradient, γ is 
the gyromagnetic ratio, G is the strength of the gradient pulse, δ is the duration of the pulse, is the 
time between the two pulses, and finally, D is the diffusion-coefficient. 
 
By rearranging the formula to isolate the diffusion-coefficient, it is possible to obtain an idea of the 
properties of diffusion occurring within a particular voxel (volume picture element). These values, 
called apparent diffusion coefficients (ADC) can then be mapped as an image, using diffusion as the 
contrast. The first successful clinical application of DWI was in imaging the brain following stroke in 
adults. Areas which were injured during a stroke showed up "darker" on an ADC map compared to 
healthy tissue. At about the same time as it became evident to researchers that DWI could be used to 
assess the severity of injury in adult stroke patients, they also noticed that ADC values varied 
depending on which way the pulse gradient was applied. This orientation-dependent contrast is 
generated by diffusion anisotropy, meaning that the diffusion in parts of the brain has directionality. 
This may be useful for determining structures in the brain which could restrict the flow of water in 
one direction, such as the myelinated axons of nerve cells (which is affected by multiple sclerosis). 
However, in imaging the brain following a stroke, it may actually prevent the injury from being seen. 
To compensate for this, it is necessary to apply a mathematical operator, called a tensor, to fully 
characterize the motion of water in all directions. 
 
3.  MR SPECTROSCOPY (MRS) 
 
 
Magnetic resonance spectroscopy (MRS) is used to measure the levels of different metabolites in 
body tissues. MR spectra may be obtained from different nuclei, including phosphorus (
31
P), fluorine 
(
19
F), carbon (
13
C) and sodium (
23
Na). The ones mostly used for clinical MRS are protons (
1
H) 
16
. The 
brain is ideally imaged with Proton Magnetic Resonance Spectroscopy (H-MRS) because of its near 
lack of motion (this prevents MRS from being used in the abdomen and thorax without very 
sophisticated motion-reduction techniques). Protons (
1
H) are the most used nuclei for clinical 
applications in the human brain mainly because of its high sensitivity and abundance. The proton MR 
spectrum is altered in almost all neurological disorders. The MR signal produces a spectrum of 
resonances that correspond to different molecular arrangements of the isotope being "excited". This 
signature is used to diagnose certain metabolic disorders, especially those affecting the brain, and to 
provide information on tumor metabolism. 
Magnetic resonance spectroscopic imaging (MRSI) combines both spectroscopic and imaging 
methods to produce spatially localized spectra from within the sample or patient. The spatial 
resolution is much lower (limited by the available SNR), but the spectra in each voxel contains 
information about many metabolites. Because the available signal is used to encode spatial and 
spectral information, MRSI requires high SNR achievable only at higher field strengths. 
 
Basic principle: 
 
H-MRS is based on the chemical shift properties of the atom. When a tissue is exposed to an external 
magnetic field, its nuclei will resonate at a frequency (f) that is given by the Larmor equation: 
 
f = γB0 
 
Since the gyromagnetic ratio (γ) is a constant of each nuclear species, the spin frequency of a certain 
nuclei (f) depends on the external magnetic field (B0) and the local microenvironment. The electric 
shell interactions of these nuclei with the surrounding molecules cause a change in the local magnetic 
field leading to a change on the spin frequency of the atom (a phenomenon called chemical shift). The 
value of this difference in resonance frequency gives information about the molecular group carrying 
1H and is expressed in parts per million (ppm). The resonant frequency, energy of the absorption and 
the intensity of the signal are proportional to the strength of the magnetic field. 
 
Chemical shift: Depending on their local chemical environment, different nuclei in a molecule absorb 
at slightly different frequencies. Since this resonant frequency is directly proportional to the strength 
of the magnetic field, the shift is converted into a field-independent dimensionless value known as the 
chemical shift. The chemical shift is reported as a relative measure from some reference resonance 
frequency. (For the nuclei 
1
H, 
13
C, and 
29
Si, TMS (tetramethylsilane) is commonly used as a 
reference.) This difference between the frequency of the signal and the frequency of the reference is 
divided by frequency of the reference signal to give the chemical shift. The frequency shifts are 
extremely small in comparison to the fundamental NMR frequency. A typical frequency shift might 
be 100 Hz, compared to a fundamental NMR frequency of 100 MHz, so the chemical shift is generally 
expressed in parts per million (ppm). To detect such small frequency differences the applied magnetic 
field must be constant throughout the sample volume. High resolution NMR spectrometers use shims 
to adjust the homogeneity of the magnetic field to parts per billion (ppb) in a volume of a few cubic 
centimeters. In general, chemical shifts for protons are highly predictable since the shifts are primarily 
determined by simpler shielding effects (electron density), but the chemical shifts for many heavier 
nuclei are more strongly influenced by other factors including excited states ("paramagnetic" 
contribution to shielding tensor). 
The chemical shift provides information about the structure of the molecule. The conversion of the 
raw data to this information is called assigning the spectrum. Software allows analysis of the size of 
peaks to understand how many protons give rise to the peak. This is known as integration—a 
mathematical process which calculates the area under a curve. The analyst must integrate the peak and 
not measure its height because the peaks also have width—and thus its size is dependent on its area 
not its height. However, it should be mentioned that the number of protons, or any other observed 
nucleus, is only proportional to the intensity, or the integral, of the NMR signal. 
J-coupling: Some of the most useful information for structure determination in a one-dimensional 
NMR spectrum comes from J-coupling or scalar coupling (a special case of spin-spin coupling) 
between NMR active nuclei. This coupling arises from the interaction of different spin states through 
the chemical bonds of a molecule and results in the splitting of NMR signals. These splitting patterns 
can be complex or simple and, likewise, can be straightforwardly interpretable or deceptive. This 
coupling provides detailed insight into the spacial relationship of atoms in a molecule. Coupling 
combined with the chemical shift (and the integration for protons) tells us not only about the chemical 
environment of the nuclei, but also the number of neighboring NMR active nuclei within the 
molecule. 
Magnetic inequivalence: More subtle effects can occur if chemically equivalent spins (i.e., nuclei 
related by symmetry and so having the same NMR frequency) have different coupling relationships to 
external spins. Spins that are chemically equivalent but are not indistinguishable (based on their 
coupling relationships) are termed magnetically in equivalent. 
 
Techniques: 
 
The H-MRS acquisition usually starts with anatomical images, which are used to select a volume of 
interest (VOI), where the spectrum will be acquired. For the spectrum acquisition, different techniques 
may be used including single- and multi-voxel imaging using both long and short echo times (TE). 
Each technique has advantages and disadvantages and choosing the right one for a specific purpose is 
important to improve the quality of the results. 
Single Voxel Spectroscopy: In single voxel spectroscopy (SVS) the signal is obtained from a voxel 
previously selected. This voxel is acquired from a combination of slice-selective excitations in three 
dimensions in space, achieved when a RF pulse is applied while a field gradient is switched on. It 
results in three orthogonal planes and their intersection corresponds to the voxel of interest. There are 
two main techniques: point resolved spectroscopy (PRESS) and stimulated echo acquisition mode 
(STEAM). 
In the PRESS sequence, the spectrum is acquired using one 90 degree pulse followed by two 180 
degree pulses. Each of them is applied at the same time as a different field gradient. Thus, the signal 
emitted by the VOI is a spin echo. The first 180 degree pulse is applied after a time ½ TE from the 
first pulse (90 degree pulse) and the second 180 degree is applied after a time ½ TE + TE. The signal 
occurs after a time 2TE (Fig. 3). To restrict the acquired sign to the VOI selected, spoiler gradients are 
needed. Spoiler gradients dephase the nuclei outside the VOI and reduce their signal. 
 
In the STEAM sequence all three pulses applied are 90 degree pulses. As in PRESS, they are all 
simultaneous with different field gradients. After a time ½ TE from the first pulse, a second 90 degree 
pulse is applied. The time elapsed between the second and the third is conventionally called ―mixing 
time‖ (MT) and is shorter than ½ TE. The signal is finally achieved after a time TE + MT from the 
first pulse. Thus, the total time for STEAM technique is shorter than PRESS. Spoiler gradients are 
also needed to reduce signal from regions outside the VOI. 
 
Multivoxel spectroscopy: Multivoxel spectroscopy has the advantage of being able to collect pieces of 
data from multiple voxels of interest simultaneously, enabling the understanding of the spatial 
heterogeneity of the distribution of metabolites. The method is known as Chemical Shift Imaging 
(CSI) or 2D Magnetic Resonance Spectroscopy Imaging (MRSI). The same sequences used for SVS 
are used for the signal acquisition in MRSI (STEAM or PRESS). The main difference between 2D 
MRSI and SVS is that, after the RF pulse, phase encoding gradients are used in two dimensions to 
sample the k-space. The results are expressed in the form of a spectroscopy grid, with spectra 
associated with each voxel in a grid. 
 
Water Suppression - Techniques and Utility: MRS-visible brain metabolites have a low concentration 
in brain tissues. Water is the most abundant and thus its signal in MRS spectrum is much higher than 
that of other metabolites (the signal of water is 100.000 times greater than that of other metabolites). 
To avoid this high peak from water to be superimpose on the signal of other brain metabolites, water 
suppression techniques are needed. The most commonly used technique is chemical shift selective 
water suppression (CHESS) which pre-saturates water signal using frequency selective 90o pulses 
before the localizing pulse sequence. Other techniques sometimes used are VAriable Pulse power and 
Optimized Relaxation Delays (VAPOR) and Water suppression Enhanced through T1 effects (WET). 
 
Acquisition parameters - Long and Short TE: It is important to note that MRS can be obtained using 
different TEs that result in distinct spectra. Short TE refers to a study in which it varies from 20 to 40 
ms. It has a higher SNR and less signal loss due to T2 and T1 weighting than long TE. These short TE 
properties result in a spectrum with more metabolites peaks, such as myoinositol and glutamine-
glutamate whichare not detected with long TE. However the baseline is more complicated due to the 
increased lipid and macromolecular background signals. 
MRS spectra may also be obtained with long TEs, from 135 to 288 ms. Long TEs have a worse SNR, 
but they have simpler spectra due to suppression of some signals. Thus, the spectra are less noisy but 
have a limited number of sharp resonances. Hence interpretation and analysis of the spectra are 
simpler. Also Lactate and alanine peaks are inverted, helping to differentiate them from the lipid / 
macromolecules peaks. With even longer TRs the SNR improves further. However this improvement 
comes at the expense of longer scan times. As the main limitation of MRS is the long scan times, this 
is undesirable and all clinical applications of  under the curve formed by the metabolite resonance 
peak is proportional to the concentration of MRS have a TE less than 3 sec. 
 
Quantification methods: As we know the area that specific metabolite. By the mathematical process of 
integration, we can quantify metabolites. Both absolute and relative concentrations can be obtained. 
However though absolute concentrations are more accurate, they are often not reproducible and errors 
in measurement are much higher. An easier and better method is to use metabolite ratios. Creatinine is 
a metabolite the concentration of which does not often changes during disease processes, and is hence 
used as an internal standard. Though the assumption that the concentration of creatinine remains 
constant over time is not always true, it is almost always true. Hence ratios are widely used as the best 
spectroscopic quantification method in following the course of neurologic diseases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: The above figure shows a spectrum obtained from the centrum semiovale of a normal person. 
The most prominent peak is N-acetyl aspartate at 2.02ppm. Following from right to left: creatine (Cr) 
at 3.02 (and 3.9), choline (Cho) at 3.2 and myoinositol at 3.56 ppm.
 4.  PATHOGENESIS 
 
HIV is a retrovirus that has a unique replication cycle. The retrovirus enters a target cell by binding to 
a specific cell-surface receptor; once the virus is internalized, its RNA is released from the 
nucleocapsid and is reverse-transcribed into proviral DNA. The provirus is inserted into the genome 
and then transcribed into RNA; the RNA is translated; and new viruses assemble and are extruded 
from the cell membrane by budding
17
. The hallmark of HIV disease is a profound immunodeficiency 
resulting primarily from a progressive quantitative and qualitative deficiency of the subset of T 
lymphocytes referred to as helper T cells (CD4+) occurring in a setting of polyclonal immune 
activation. Patients with CD4+ T cell levels below certain thresholds are at high risk of developing a 
variety of opportunistic diseases. 
Apart from opportunistic infections, HIV can cause damage to the CNS as a direct result of viral 
infection of the CNS macrophages or glial cells or secondary to the release of neurotoxins and 
cytokines. In addition genetic variables may influence susceptibility of patients to CNS disease
17
. 
Virtually all patients with HIV infection have some degree of nervous system involvement with the 
virus. This is evidenced by the fact that CSF findings are abnormal in ~90% of patients, even during 
the asymptomatic phase of HIV infection. CSF abnormalities include pleocytosis (50– 65% of 
patients), detection of viral RNA (~75%), elevated CSF protein (35%), and evidence of intrathecal 
synthesis of anti-HIV antibodies (90%). 
Pathologically, characteristic changes are seen in the brains of persons with HIV which can exist 
singly or overlap. The most common finding is cerebral atrophy with resultant ventricular 
enlargement and widened sulci. Extensive inflammatory changes are seen in both the deep white 
and deep gray matter. Distinct pockets of inflammatory cells, such as microglia, macrophages, 
and multinucleated giant cells formed by fusion of microglia and macrophages, are found in white 
and deep grey matter as well as in the cortex. In addition to neurons, glial cells also harbour HIV. 
HIV leukoencephalopathy is characterized by diffuse damage to white matter or myelin 
attenuation, astrogliosis, macrophages, and multinucleated giant cells without distinct pockets of 
inflammation
18
. Electron microscopy shows the multinucleate giant cells to be packed with 
retrovirus particles. The presence of these viral loaded cells is strongly associated with AIDS 
Dementia complex
7
. HIV related poliodystrophy is a diffuse atrophy of the gray matter. Reactive 
astrogliosis and microglial activation in cerebral gray matter may possibly be associated with neuron 
loss or dendritic damage. Severe cases may also evidence spongiform changes. Demyelination 
apparent on imaging is a comparatively late finding
7,18
. 
Vascular calcification of the basal ganglia and possibly the centrum semiovale is often present in 
pediatric AIDS. In fact, it may be found either with or without notable HIV-1 encephalitis. Areas of 
myelin pallor in young children may be difficult to distinguish because of their incomplete 
myelination. In contrast, inflammatory changes are more common in the spinal cord in pediatric 
patients, whereas vacuolar myelopathy is seen less often. However, corticospinal tract degeneration 
may also be found in pediatric HIV-1 infection
18
. 
 
5.  PATHOLOGIC, MR IMAGING, AND MR SPECTROSCOPIC FEATURES 
 
Toxoplasmosis: 
 
Toxoplasmosis is the most frequent cause of intracranial mass lesion in the HIV positive 
population
19
. It is an obligate intracellular protozoan. Transmission of infection occurs commonly 
through the ingestion of food or water contaminated with cat feces, or transplacentally. Infection is 
widespread in the community. Immunocompetent people generally control the infection adequately 
and do not require medical intervention, though persistent latent infection is the norm
17
. In 
immunocompromised hosts, however, may have either reactivation of latent infection, or be unable to 
control a de novo infection. Toxoplasma encephalitis occurs when the CD4+ count falls below 100 
cells/μl 
17
. Pathological examination of toxoplasma lesions reveal a laminated structure consisting of 
three distinct zones
7
. First, there is a central necrotic avascular zone, containing few organisms. 
Surrounding this is a region engorged with blood vessels with numerous active organisms 
(tachyzoites). This region is very vascular and undergoes an intense inflammatory reaction with 
thrombosis of small vessels and migration of many inflammatory cells into it. Peripheral to this is 
again a relatively avascular zone containing fewer active organisms and more dormant forms 
(bradyzoites)
7,20
. MR features of cerebral toxoplasmosis vary depending upon activity of the 
lesion, immune status of patient and administration of steroids. These lesions, usually multiple, 
are characteristically located at the basal ganglia (most common), the thalami, and at the gray-
white matter junction, and rarely the brainstem
21
. There is usually mass effect with extensive 
surrounding edema. Though they are usually T2 hyperintense, the characteristic target sign 
consists of a T2 hypointense lesion surrounded by vasogenic edema. They are hypointense on 
T1W sequences and enhance in a ring or nodular fashion on Gadolinium administration, typically 
ring enhancing with an eccentric nodule. Enhancement decreases with therapy or decreasing 
CD4+ cell count
21
. Hemorrhage is rare
7
. DWI shows increased diffusivity. Spectroscopy reveals 
marked elevation of lipid and lactate peaks. All other brain metabolites are markedly diminished. This 
is particularly important since the main differential on imaging as well as clinically is primary CNS 
lymphoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. shows multilple T2 hyperintense lesions throughout the brain, with the largest located in the right 
Parietal lobe with extensive surrounding edema, which shows peripheral enhancement. These are 
typical findings in Toxoplasmosis.
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
             
Fig shows Spectrum obtained from a Toxoplasma lesion, with reduction in all metabolites, but with a 
prominent lactate resonance. 
 
Primary CNS Lymphoma 
 
PCNSL accounts for 1%–5% of all brain tumors and 1% of all NHLs in the body22. It develops almost 
exclusively in immunosuppressed populations such as in HIV positive patients, Organ transplant 
recipients, or inherited immunodeficiency disorders
23
. It is estimated that upto 3% of AIDS patients 
develop PCNSL
23
. They generally present as focal intraaxial masses though subarachnoid space 
involvement is common in recurrent disease
7
. Upto a quarter of patients may have concurrent or prior 
involvement of the vitreous of the eye
23
. Primary intraocular lymphoma has also been described, 
though it is rare
22
. The location of the lesion is usually supratentorial (75 to 80%), involving the deep 
gray matter, periventricular regions and corpus callosum, usually in contact with the ependyma. AIDS 
related PCNSL is multifocal in 30-80% of cases
22
, however involvement outside the CNS is a late and 
infrequent occurrence
20
. Most primary brain lymphomas are of B-cell origin and diffuse large-cell B-
cell lymphomas are the most common histologic group. In the setting of immunosuppression, the cells 
in nearly all such tumors are latently infected by Epstein-Barr virus, and this is useful in that markers 
of Epstein-Barr viral infection can be used as an aid in diagnosis. Within the tumor malignant cells 
infiltrate the parenchyma of the brain and accumulate around blood vessels. Reticulin stains 
demonstrate that the infiltrating cells are separated from one another by silver-staining material; this 
pattern, referred to as ―hooping,‖ is characteristic of primary brain lymphoma
20
. On unenhanced T1-
weighted MR imaging, lesions are typically described as hypo-or isointense and on T2-weighted MR 
imaging, iso- to hyperintense, though these tumors may often be hypointense to gray matter
22
. Most 
lesions show moderate-to-marked contrast enhancement on Gadolinium administration. Isolated white 
matter hyperintensity on T2W sequences, or no contrast enhancement on T1- weighted MR imaging 
has also been described in some rare cases of PCNSL
22
. Other features of PCNSL that have been 
described on morphological MRI (Though for immunocompetent patients) are ―notch sign,‖ an 
abnormally deep depression at the tumor margin, and ―open ring enhancement
24
. There could be 
mild or marked perilesional oedema, which however is less than that of metastases or 
glioblastoma
7,25
. Hemorrhage or internal calcifications within the tumor are a quite rare finding. 
Because CNS lymphomas are highly cellular tumors, water diffusion is often restricted, making them 
appear hyperintense on DWI and hypointense on ADC maps
24
. PWI shows an elevated rCBV, which 
helps differentiate from toxoplasmosis
7
. 
In PCNSL, MR spectroscopy demonstrates elevated choline and lipid / lactate peaks combined with 
high Cho/Cr ratios
22
. NAA peak is reduced. Cho/NAA and lactate/Cr ratios are also increased when 
compared to normal gray matter
26
. These can also be seen in glioblastoma multiforme and metastases 
but may help in differentiating PCNSL from other lesions, particularly toxoplasmosis. 
 
PML 
 
Progressive multifocal leukoencephalopathy (PML) is a fulminating opportunistic infection of the 
brain that occurs in approximately 4% of AIDS patients; it is caused by the JC papovavirus. Primary 
infection with JC virus occurs in childhood and remains latent. In the setting of severely altered 
cellular immunity, this virus causes extensive myelin breakdown and white matter destruction, 
because of its targeting of the oligodendrocytes, the cell responsible for the production of myelin
21
. 
On pathologic examination of the brain, patches of irregular, ill-defined destruction of the white 
matter ranging in size from millimeters to extensive involvement of an entire lobe of the brain are 
seen. On microscopic examination the typical lesion consists of a patch of demyelination, most often 
in a subcortical location, in the center of which are scattered lipid laden macrophages and a reduced 
number of axons. At the edge of the lesion are greatly enlarged oligodendrocyte nuclei with glassy 
amphophilic viral inclusions which contain viral antigens by immunohistochemistry. Within the 
lesions, there may be bizarre giant astrocytes with one to several irregular, hyperchromatic nuclei 
mixed with more typical reactive astrocytes. Imaging studies show extensive, often multifocal lesions 
in the hemispheric or cerebellar white matter. In fact a posterior location, though not pathognomonic 
is considered supportive evidence for a diagnosis of PML
21
. These lesions start subcortically
21
 (the 
site of highest blood flow), then extend into the deep white matter. They demonstrate rapid 
progression in size, resulting in confluence of the lesions. Extensive white matter high signal on T2W 
/FLAIR imaging with sparing of the cortical gray matter is the hallmark of this infection. The lesions 
are initially round or oval but rapidly progress to become confluent and large, leading to poor 
prognostic outcomes characteristic of this aggressive disorder. Lesions of PML can be distinguished 
from those of TE by their nonenhancing character
8
. Contrast enhancement, however, especially when 
faint and peripheral, does not exclude a PML diagnosis
21
 and has been considered by Berger et al to 
be one of the factors predictive of prolonged survival in AIDS patients with PML
27
, along with higher 
CD4 counts, possibly because of the patient‘s ability to mount a better response. The lesions may 
show a central area of hyperintensity on T2W MR Images, resembling necrosis. It has also been 
demonstrated that cortical atrophy and ventricular dilation are not prominent features of PML, 
although follow-up studies have suggested some atrophic progression along with increased 
hypointensity on T1- weighted images
28
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Figures above show a T1 hypointense, T2 hyperintense lesion in the white matter of the right middle 
cerebellar peduncle. It shows no enhancement on post gadolinium images. This was a case of PML. 
 
Hyperintensity on FLAIR Sequence, the inversion recovery sequence which is used to null signal 
from fluid, is usually due to true progression of PML and is associated with a poor prognosis
28
. In 
contrast, hypointensity on FLAIR may represent a ―burnt-out‖ process of PML and is associated with 
longer survival. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure shows subcortical white matter hyperintensity in both parietal lobes sparing the cortical gray 
matter in a case of PML. 
 
PML is characterized on proton MR spectroscopy by a reduction in the NAA peak and elevation in the 
choline (Cho) and occasionally myoinositol (mI) peaks, with decrease in the NAA/Cr ratio and an 
increase in the lactate/Cr, Cho/Cr, and lipids/Cr ratios
29,30
. There are a few differences in the spectra 
obtained from patients with PML only, and PML with IRIS (Immune reconstitution inflammatory 
syndrome), but the most consistent in one large series is the mI/Cr ratio which was more elevated in 
patients with PML with IRIS
31
. The level of mIns depends upon the stage of the disease. In early and 
active stage, there is increased level of mIns that gradually decreases to normal level in late quiescent 
stage
32
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig shows MR Spectroscopy obtained from a lesion in a case of PML reveals reduced NAA peak, 
along with prominent Choline and myoInositol peaks. 
 
 HIV Encephalopathy 
 
Neurologic problems directly attributable to HIV occur throughout the course of infection and may be 
inflammatory, demyelinating, or degenerative in nature. The term HIV- associated neurocognitive 
disorders (HAND) is used to describe a spectrum of disorders that range from asymptomatic 
neurocognitive impairment (ANI) to minor neurocognitive disorder (MND) to clinically severe 
dementia
17
. The most severe form, HIV-associated dementia (HAD), also referred to as the AIDS 
dementia complex, or HIV encephalopathy, is considered an AIDS-defining illness. This consists of 
disabling cognitive, behavioral, and motor impairment associated with HIV and has been reported in 
up to 15% of HIV-infected adult patients
18
, though approximately 50% of HIV-infected individuals 
can be shown to have mild to moderate neurocognitive impairment using sensitive neuropsychiatric 
testing
17
. While this is generally a late complication of HIV infection that progresses slowly over 
months, it can be seen in patients with CD4+ T cell counts >350 cells/μl. HIV-associated dementia is 
the initial AIDS-defining illness in only about 3% of patients with HIV infection and thus only rarely 
precedes clinical evidence of immunodeficiency. 
 
The precise cause of HIV-associated dementia remains unclear, although the condition is thought to 
be a result of a combination of direct effects of HIV on the CNS and associated immune activation. 
HIV has been found in the brains of patients with HIV encephalopathy by Southern blot, in situ 
hybridization, PCR, and electron microscopy. Multinucleated giant cells, macrophages, and microglial 
cells appear to be the main cell types harboring virus in the CNS. Histologically, the major changes 
are seen in the subcortical areas of the brain and include pallor and gliosis, multinucleated giant cell 
encephalitis, and vacuolar myelopathy
17
. Less commonly, diffuse or focal spongiform changes occur 
in the white matter. Areas of the brain involved in motor, language, and judgment are said to be most 
severely affected. Rather than having a specific pathologic lesion as its correlate, this disorder is most 
tightly related to the extent of activated microglia in the brain, not all of which are necessarily HIV-
infected
20
. 
Imaging in general has low sensitivity in identification of early disease due to the microscopic size of 
lesions. The most frequent radiological finding is atrophy of the brain
21,33
. On MRI, unilateral hyper 
intense lesions are usually present on T2W images, mostly in the frontal lobe, and progress to bilateral 
involvement. In the later stages, MRI reveals a diagnostic pattern of abnormalities: extensive and 
symmetric involvement of the deep white matter with typically spared cortical gray matter. Contrast 
enhancement and mass effect are not features of lesions in HIV encephalitis
33
. 
 
Among MRI techniques, magnetization transfer ratio (MTR) may be used to demonstrate 
macromolecular destruction (myelin and axonal loss) in HIV encephalitis and may help early 
diagnosis and in differentiation between PML by showing a degree of destruction which is more 
pronounced in PML
34
. 
MRS studies consistently reveal a severe reduction of NAA in the cortex and frontal white matter in 
those patients with HIV encephalopathy with more severe cognitive impairment. Furthermore, 
increasing levels of Cho and mI in the basal ganglia and the frontal white matter were also associated 
with an increasing severity of cognitive impairment and a greater decline in CD4 count
8
. With the 
onset of widespread HAART for HIV positive patients, studies began to focus on whether 
improvement of the metabolic parameters occurred. HAART was found to impove HIV 
encephalopathy in addition to systemic measures of HIV infection. MRS studies in these patients 
detected improvement of brain injury measured by cerebral metabolites, particularly the glial marker 
mI, in patients with early HIV encephalopathy after HAART
35,36
. In addition, the degree of 
improvement in clinical severity of the disease is related to the degree of recovery with mI
35
. 
 
Other studies were directed towards detecting onset of HIV associated neuronal damage in the brain. 
In a landmark study by Ratai et al
37
, MRS was used to monitor metabolite abnormalities in the basal 
ganglia, frontal cortex, and white matter in SIV-infected macaques (An animal model of AIDS) from  
  
initial infection until 4 weeks post infection. At peak viremia 2 weeks postinfection, a significant 
decrease in NAA and NAA/Cr and a significant increase in Cr were found only in the frontal cortex, 
indicating a localized decline in neuronal integrity coupled with increased energy consumption in this 
region. Conversely, mI and mI/Cr levels increased across all three regions of interest, indicating 
microglial activation and astrogliosis and the resultant mounting of global inflammation regardless of 
the region of brain sampled.         
             
 
            
            
            
            
            
            
            
            
       
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures show deep white matter T2 and Flair hyperintensity with T1 hypointensity in both cerebral 
hemispheres in conjunction with prominent cortical sulci and ventricular system, findings seen in 
relatively advanced HIV Encephalopathy. 
 
Additionally, Cho and Cho/Cr levels increased initially in all three abovementioned regions at peak 
viremia, indicating macrophage infiltration, but then decreased below baseline by the fourth week. 
Further studies of patients with early HIV infection confirmed some of these findings including a 
sharp decline of NAA in the frontal cortex that was significantly correlated with expansion of CD8+ T 
cells. 
 
 Thus, neuronal injury occurs in the frontal cortex soon after infection with HIV
38
, suggesting that an 
increase in NAA may serve as a surrogate marker for therapy effectiveness in early stage treatment 
regimens. Also, Patients with HIV associated neurocognitive disorders have also been found to have 
lower levels of Glx (Glutamine / Glutamate) concentrations and Glx/Cr ratio in FWM, which was 
associated with impaired performance in specific cognitive domains, including executive functioning, 
fine motor, attention and working memory performance
39
. 
MRS also shows alterations in the spectra of asymptomatic patients with HIV. In HIV patients, the 
NAA/Cho ratio was significantly lower, with lower values of NAA correlating with the CD4+ 
count
40
. A significant increase in Cho/Cr and mI/Cr ratios in asymptomatic HIV patients was also 
found, which increased further in patients with HIV encephalopathy
41
. The difference of NAA/Cr 
was more pronounced in the white matter than in the gray matter
42,43
. These results suggest that 
MRS is more sensitive than conventional MR imaging in detecting CNS involvement in 
neurologically asymptomatic HIV patients
42
 and may, therefore, be used for early detection of brain 
damage induced by HIV. 
Age and duration of HIV infection also, as expected, appear to have a significant impact on the brain. 
HIV and age interaction was associated with lower frontal white matter NAA. CVD risk factors were 
associated with NAA in both the gray and white matter in both groups. Past acute CVD events in the 
HIV positive patients were associated with increased mI in the cortex. Longer HIV duration was 
associated with lower NAA peaks in the grey matter. 
While these findings are fundamental to our understanding of the underlying metabolic mechanisms 
behind the progression of cognitive decay in patients with HIV dementia, more research is needed to 
determine how HIV affects those in the early disease stage as well as asymptomatic subjects. MRS 
has proven to be a very useful tool in studies aimed at understanding how HIV infection affects the 
CNS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig shows MR Spectrum obtained from the white matter in a case of HIV Encephalopathy, with 
reduced NAA peak and mildly raised choline peak. 
 
 Cryptococcosis 
 
Cryptococcus neoformans is an opportunistic fungal pathogen that affects mainly 
immunocompromised patients. It is the most common fungus to involve the CNS and the most 
common fungal infection to occur in AIDS patients
7
. The primary site of infection is the lung, and 
infection is acquired via the inhalation of aerosolized spores
17
 from soil or from pigeon droppings. 
The infection can present as meningoencephalitis, encephalitis, cryptococcoma or an abscess, of 
which meningitis is the most common manifestation
33
. 
Cryptococcus has yeast but not pseudohyphal or hyphal forms. The 5- to 10 μm cryptococcal yeast 
has a highly characteristic thick gelatinous capsule. Although the lung is the primary site of infection, 
pulmonary involvement is usually mild and asymptomatic, even while the fungus is spreading to the 
CNS. The major lesions caused by C. neoformans are in the CNS, involving the meninges, cortical 
gray matter, and basal nuclei. In immunosuppressed people, organisms may evoke virtually no 
inflammatory reaction, so gelatinous masses of fungi grow in the meninges or expand the perivascular 
Virchow-Robin spaces within the gray matter, producing the so-called soap-bubble lesions. In patients 
with protracted disease, the fungi induce a chronic granulomatous reaction composed of macrophages, 
lymphocytes, and foreign body type giant cells
20
, causing mass lesion called cryptococcomas. 
Neuroimaging studies can reveal four basic patterns. First, parenchymal cryptococcomas may be seen. 
Secondly, there may be numerous clustered small, round or oval cystic foci that were hypointense or 
slightly hyperintense on T1W and hyperintense on T2W images and non-enhancing on postcontrast 
T1-weighted images, located relatively symmetrically in the basal ganglia bilaterally and in midbrain, 
representing dilated Virchow-Robin spaces filled with gelatinous exudate. These dilated VR spaces 
seen at the basal regions of the brain are also named as ―gelatinous pseudocysts‖ or ―soap bubble 
lesions‖, and they do not enhance with Gadolinium
44
 as they do not disrupt the blood brain barrier 
and are rarely associated with inflammatory edema. Third, there may be multiple miliary 
parenchymal and leptomeningeal nodules. This is a more fulminant form of CNS cryptococcosis 
where there is disruption of the blood brain barrier and subsequent parenchymal seeding. These 
cryptococcomas appear as multiple enhancing leptomeningeal or parenchymal nodules. Fourth, a 
mixed pattern, consisting of dilated Virchow-Robin spaces with mixed lesions such as 
cryptococcoma and miliary nodules may be seen
45
. On diffusion-weighted images, there may be 
restricted diffusion in some of the lesions due to the high viscosity of their contents
44
. 
 
 
 
 
 
 
 
 
 
 
Fig shows T2 hyperintense focal lesions in the right basal ganglia, which suppress on FLAIR 
sequence. These are dilated perivascular spaces seen in cryptococcosis. 
 
 
 MR spectroscopy from cryptococcomas demonstrate a decrease in N-acetyl-aspartate (NAA), slight 
increase of choline (Cho), presence of lipids, trehalose and, in some cases, presence of lactic acid
44
. 
This correlates with an inflammatory lesion in the brain with neuronal destruction. Spectra of fungal 
abscesses in general are known to show peaks corresponding to lipids, lactate, alanine, acetate, 
succinate and choline
46
. Early in vitro studies showed that MR spectra of C neoformans and cerebral 
cryptococcomas--but not of other fungi, healthy brains, or gliomas--were dominated by resonances 
from the cytosolic disaccharide alpha, alpha trehalose MR spectra of C. neoformans and cerebral 
cryptococcomas--but not of other fungi, were dominated by resonances from the cytosolic 
disaccharide alpha, alpha trehalose
47
 from the fungal capsule. Hence a remarkably high concentration 
of alpha, alpha trehalose in relation to other metabolites that are visible with MR spectroscopy is 
diagnostic of C neoformans
47
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig shows MR Spectrum obtained from a case of cryptococcosis with reduced NAA peak and raised 
choline peak, findings which are suggestive of ongoing inflammation.. 
 
CNS Tuberculosis 
 
Central nervous system (CNS) disease caused by Mycobacterium tuberculosis is highly devastating, 
and accounts for approximately 1% of all cases of tuberculosis. It carries a high mortality and a 
distressing level of neurological morbidity, and disproportionately afflicts children and human 
immunodeficiency virus (HIV) infected. 
The link between HIV and coinfection with tuberculosis runs deep. World Health Organization 
estimates that 9.27 million new cases of TB occurred in 2007 (139/100,000 population), compared 
with 9.24 million new cases (140/100,000 population) in 2006 world over
48
. India, China, Indonesia, 
Nigeria, and South Africa rank first to fifth in the total number of incident cases. Among the 15  
  
Countries with the highest estimated TB incidence rates, 13 are in Africa, a phenomenon linked to the 
effect of high rates of HIV coinfection on the natural history of TB
49
. Incidence rates are falling 
world over except in Eastern Europe, where it is stable and increasing only in African countries with a 
low prevalence of HIV
48
. Among the 9.27 million incident cases of TB in 2007, an estimated 1.37 
million (14.8%) are HIV-positive
48
. The global number of incident HIV-positive TB cases is 
estimated to have peaked in 2005 at 1.39 million. The relative risk of developing TB in HIV-positive 
people compared to HIV-negative people (the incidence rate ratio) is 20.6 in countries with a HIV 
prevalence greater than 1% in the general population, about 26.7 where HIV prevalence range from 
0.1% and 1%, and 36.7 in countries with a prevalence less than 0.1%
50
. 
Mycobacterium tuberculosis, the bacillus responsible for tuberculosis reaches the CNS by the 
haematogenous route secondary to disease elsewhere in the body. CNS tuberculosis develops in two 
stages. Initially small tuberculous lesions (Rich‘s foci) develop in the CNS, either during the stage of 
bacteraemia of the primary tuberculous infection or shortly afterwards. These initial tuberculous 
lesions may be in the meninges, the subpial or subependymal surface of the brain or the spinal cord, 
and may remain dormant for years after initial infection. Later, rupture or growth of one or more of 
these small tuberculous lesions produces development of various types of CNS tuberculosis. The 
specific stimulus for rupture or growth of Rich‘s foci is not known, although immunological 
mechanisms are believed to play an important role. Rupture into the subarachnoid space or into the 
ventricular system results in meningitis. The type and extent of lesions that result from the discharge 
of tuberculous bacilli into the cerebrospinal fluid (CSF), depend upon the number and virulence of the 
bacilli, and the immune response of the host. Infrequently, infection spreads to the CNS from a site of 
tuberculous otitis or calvarial osteitis. The pathogenesis of localized brain lesions is also thought to 
involve haematogenous spread from a primary focus in the lung (which is visible on the chest 
radiograph in only 30% of cases)
51
. It has been suggested that with a sizeable inoculation or in the 
absence of an adequate cell-mediated immunity, the parenchymal cerebral tuberculous foci may 
develop into tuberculoma or tuberculous brain abscess. 
 
Manifestations of CNS tuberculosis may be as follows
51
: 
 
A.  Intracranial 
 
 Tuberculous meningitis (TBM), with or without miliary tubercles  
 
 Tuberculous encephalopathy  
 
 Tuberculous vasculitis  
 
Space-occupying lesions: These might be tuberculomas (single or multiple), multiple small 
tuberculomas with miliary tuberculosis or tuberculous abscess  
 
B. Spinal  
 
 Pott‘s spine  
 
 Tuberculous arachnoiditis (myeloradiculopathy)  
 
 Intramedullary spinal tuberculoma  
 
 Spinal meningitis  
 Tuberculous meningitis is not the most common but it is considered to be the most serious clinical 
form of extrapulmonary tuberculosis
52
. It is the most common cause of chronic meningitis, especially 
in developing countries
53
. In HIV-infected patients, TB is more likely to produce meningitis
54
. 
Common findings on imaging are abnormal meningeal enhancement in the basal cisterns, 
hydrocephalus, and vascular complications
53
. During the early stages of the disease, noncontrast MRI 
studies usually show little or no evidence of any meningeal abnormality. With disease progression, 
swelling of the affected subarachnoid spaces occurs with associated mild shortening of T1 and T2 
relaxation times in comparison with normal CSF. Postcontrast T1W images show abnormal meningeal 
enhancement, especially in the basal cisterns. Cisternal enhancement is often quite striking and is far 
better demonstrated by postgadolinium MR than by CT
7
. Commonly involved sites are the 
interpeduncular fossa, pontine cistern, and the perimesencephalic and suprasellar cisterns. 
Involvement of the sulci over the convexities and of the Sylvian fissures can also be seen. Cerebellar 
meningeal and tentorial involvement is uncommon. The meningeal enhancement can also present as 
ependymitis. FLAIR sequence is more sensitive than T2 weighted images in depicting these 
abnormalities. Rarely, when the dura mater is involved, a focal thickening, known as pachymeningitis, 
associated with contrast enhancement develops and may or may not calcify. Hydrocephalus is a 
common sequela of tuberculous meningitis, and its presence is related to poor prognosis. The thick 
and gelatinous inflammatory exudate within the basal cisterns impedes the cerebrospinal fluid from 
circulating and being absorbed. Thus, communicating hydrocephalus develops, which can be 
documented by both CT and MR. The hydrocephalus occasionally may be obstructive, secondary to a 
focal parenchymal lesions with mass effect or due to entrapment of a ventricle by granulomatous 
ependymitis
7
. Periventricular hyperintensity on proton density and T2W images is due to the seepage 
of the CSF fluid across the white matter and usually suggests hydrocephalus under pressure, which is 
an indication for CSF diversion surgery to decompress the ventricular system. Chronic hydrocephalus 
may result in atrophy of the brain parenchyma. Endoscopic third ventriculostomy is a procedure 
gaining acceptance as patency of the stoma can be demonstrated by CSF flow dynamics
55
 on MRI. 
 
 
 
 
 
 
 
 
 
 
 
Fig shows thick enhancing exudates in the interpeduncular and chiasmatic cisterns as well as the 
left sylvian fissure in a case of tuberculous meningitis. 
 
 
 
 Miliary brain tuberculosis is usually associated with TBM. Miliary tubercles are <2 mm in size and 
are either not visible on conventional SE MRI images or are seen as tiny foci of hyperintensity on 
T2W acquisitions. After gadolinium administration, T1W images show numerous, round, small, 
homogeneous, enhancing lesions. Regular spin echo sequence invisible lesions that may or may not 
enhance after intravenous injection of gadolinium are clearly visible on MT-SE T1 weighted imaging. 
MT-SE imaging helps in defining the true disease load 
53,56
 in cases of miliary tuberculosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig shows enhancing exudates in the supracerebellar cistern in this post gadolinium image with 
multiple tiny enhancing nodulesthroughout the brain parenchyma in a case of Tuberculous meningitis 
with miliary tuberculosis. 
 
Tuberculous encephalopathy is an established disease entity of diffuse cerebral damage occurring with 
tuberculosis with an underlying immune pathogenesis. Histopathology reveals demyelination and 
granuloma in the white matter. MRI shows diffuse, hyperintense lesions in the white matter on T2 
weighted images, with gadolinium enhancement on T1-weighted images
57
. 
Vasculitis is a complication that is commonly seen at autopsy in cranial TBM. The adventitial layer of 
small and medium-sized vessels develops changes similar to those of the adjacent tuberculous 
exudates. The intima of the vessels may eventually be affected or eroded by fibrinoid-hyaline 
degeneration. In later stages, the lumen of the vessel may get completely occluded by reactive 
subendothelial cellular proliferation. Ischemic cerebral infarction resulting from the vascular 
occlusion is common sequelae of tuberculous arteritis
58
. The middle cerebral and lenticulostriate 
arteries are most commonly affected
58
. MRI angiography may help in the detection of vascular 
occlusion. High-field MRA with contrast is more sensitive than conventional MRA in the 
detection of occlusion of smaller vessels that are more commonly involved by the pathology. The 
majority of the infarcts are in the basal ganglia and internal capsule due to the involvement of the 
lenticulostriate arteries
58
. Haemorrhagic infarcts are common
7,58
. Diffusion-weighted imaging 
helps in the early detection of this complication.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted diffusion is seen in the DWI sequence in the figure appended in a case of tuberculous 
meningitis. This is suggestive of vasculitic infarct. 
 
Magnetization transfer (MT) imaging is considered to be superior to conventional spin echo sequences 
for imaging abnormal meninges, which appear hyperintense on precontrast T1W MT images and 
show further enhancement on postcontrast T1W MT images
56
. In addition, MT ratio (MTR) 
quantification helps in predicting the etiology of the meningitis. Visibility of the inflamed meninges 
on precontrast T1W MT images with low MTR is specific for TBM, helping in differentiating it from 
other nontuberculous chronic meningeal infections
53
. 
There is no published study of in vivo MRI spectroscopy (MRS) in TBM; however, ex vivo 
spectroscopy of CSF has been attempted in this context 
53
. High-resolution ex vivo MRS of the CSF 
shows signals from Lac, acetate, and sugars along with cyclopropyl and phenolic glycolipids. These 
have not been observed in pyogenic meningitis. The combination of ex vivo MRS with MT MRI may 
be of value in the diagnosis of TBM
53
. 
The most common parenchymal form of CNS TB is the tuberculoma
7
. Pathologically, a tuberculoma 
is composed of a central zone with caseous necrosis, surrounded by a capsule of collagenous 
tissue,epithelioid cells, multinucleated giant cells, and mononuclear in-flammatory cells
20
. It is 
mostly infratentorial when in children, and it is supratentorial in adults
53
. Tuberculomas may be 
single or multiple, and can be seen anywhere in the brain parenchyma. Tuberculomas are best viewed 
on T2 weighted images, and are classified based on their appearance in this sequence as
59
: 
 
T2 Hyperintense 
 
These lesions are noncaseating tuberculomas which are usually less than 1.5 cm in diameter. They 
appear T2 hyperintense and T1 iso to hypointense, hyperintense on MT T1 and FLAIR sequences. On 
contrast administration, they show nodular or ring enhancement. They are bright on DW images, with 
low ADC.  
 
T2 Hypointense 
 
These are lesions with conversion of the core into solid, cheesy, caseous material, and appear iso to 
hypointense on both T2 and T1 weighted images. These lesions may show an inconsistent non 
caseating peripheral region, which may be T2 hyperintense, but T1 iso to hyperintense, and this 
enhances on contrast administration. This peripheral region pathologically is found to consist of 
inflammatory cells, debris and mycolic acid and lipid rich cell wall fragments of Mycobacterium 
tuberculosis. This makes this peripheral rim hyperintense on MT T1 sequences. The central caseous 
material however has a High ADC, with no diffusion restriction seen on the DW images. Of 
importance is the presence of serine in the area of caseation on Spectroscopic analysis, which is a 
marker for the cell walls of  Mycobacterium tuberculosis T2 hyperintense centre with T2 hypointense 
periphery: These lesions have a central core of liquefied caseous material. They may have a variably 
solid peripheral rim. This manifests on T2W images as a hyperintense lesion with a peripheral 
hypointense rim. The low signal rim in the external region is composed of collagen fibers produced by 
fibroblasts. Because the contents of collagen fibres vary, the low signal rim may be incomplete or 
absent
60
. T1W and MT T1 weighted images show this liquefied central area as hypointense, and DW 
images show diffusion retriction. There is rim enhancement on contrast administration.  
Heterointense lesion: These lesions on histologic examination are relatively rich in inflammatory cells 
with scattered areas of cheesy caseous material. These show mixed intensity signal on T2 wighted 
images. On T1 weighted images also they are minimally hyperintense. MT T1 images show 
predominantly hypointense central regions with a hyperintense rim.  On contrast administration, these 
lesions show variegated enhancement. 
 
 
 
 
 
 
 
 
 
 
Fig: The above figures show T2 hypointense ring enhancing (caseating) and T2 hyperintense disc 
enhancing lesions in an HIV positive patient s/o tuberculomas. 
 
In vivo spectra are found to be specific for intracranial tuberculomas and demonstrate the biochemical 
fingerprints of tubercle bacilli in a granuloma
53
. In vivo spectroscopy shows only lipid in T2 
hypointense tuberculomas, whereas lesions with a heterogeneous appearance show Cho at 3.22 ppm 
along with lipid. These lesions show a large amount of cellularity and minimal solid caseation, the 
cellular regions appearing brighter on MT imaging and showing Cho resonance on spectroscopy. MR 
spectroscopy has shown prominent lipid and lactate peaks in patients with proven tuberculomas 
without aminoacid resonances. Caseous material typical of tuberculomas has a high lipid content. A 
pattern of multiple peaks for lipids have been documented corresponding to a terminal methyl group, 
methylene group, and phosphoserine. . Phenolic lipids represent the biochemical fingerprint of M. 
tuberculosis in a granuloma; however, phenolic glycolipids remain present in the virulent as well as 
non-virulent strains of M. tuberculosis. On ex vivo and in vitro (lipid extract) spectroscopy, peaks of 
cyclopropane rings and phenolic glycolipid caseating tuberculomas are seen, which can be attributed 
to M. tuberculosis
53
. This spectral pattern seems to be fairly specific for caseating tuberculomas 
because other lesions such as metastases and high-grade gliomas may show lipid peaks in addition to 
other metabolite peaks, whereas tuberculomas only demonstrate prominent lipid resonances. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure shows a spectrum obtained from a Tuberculoma which demonstrates great raised lipid-
lactate resonance. 
 
Tuberculous brain abscess is a relatively rare condition caused by M. tuberculosis infection, 
constituting 4–7% of the total number of CNS TB cases in developing countries. According to the 
criteria of Whitener, tuberculous abscesses should show macroscopic evidence of abscess formation 
within the brain parenchyma and should offer histological confirmation that the abscess wall is 
composed of vascular granulation tissue containing both acute and chronic inß ammatory cells and 
M. tuberculosis
61
. 
Neuroimaging study findings are usually nonspecific for the detection of tuberculous abscesses. They 
appear as large, solitary, and frequently multiloculated, ring-enhancing lesions with surrounding 
edema and mass effect on MRI. MTR quantification from the rim of the abscess has helped in the 
diff erential diagnosis of tuberculous from pyogenic abscesses. High lipid-containing tuberculosis 
bacilli are probably responsible for the significantly lower MTR values in the rim of tuberculous 
abscesses compared with pyogenic abscesses. DWI in tuberculous abscesses shows restricted 
diffusion with low apparent diffusion coefficient (ADC) values, probably a result of the presence of 
intact inflammatory cells in the pus. 
In vivo MRS has also been used for the differentiation of tuberculous abscesses from other lesions 
such as pyogenic abscesses and fungal lesions. In vivo proton spectra in tuberculous abscesses show 
only Lac and lipid signals without any evidence of cytosolic amino acids. More lipid peaks may also 
be apparent on ex vivo spectroscopy. 
 
 
  
Pyogenic abscess 
 
Pyogenic brain abscess (BA) is defined as a focal infection within the brain parenchyma, which starts 
as a localized area of cerebritis, which is subsequently converted into a collection of pus within a 
well-vascularized capsule. Atypical brain abscesses are common in HIV infection
62
. Although 
infection with HIV-I does not predispose to pyogenic abscess formation, a considerable percentage of 
HIV-infected patients have acquired the infection and HIV patients, particularly those who are 
intravenous drug abusers are at risk for the development of pyogenic abscesses
33
. 
In a typical abscess with central liquefactive necrosis, the center of the cavity is slightly hyperintense 
to CSF, whereas the surrounding edematous brain is slightly hypointense to normal brain parenchyma 
on T1 weighted images. On T2 weighted images, signal intensities are quite variable. The rim is 
isointense to slightly hyperintense to white matter on T1 weighted images and is hypointense onT2 
weighted images. The signal properties of the rim seen on MR have been attributed to collagen, 
hemorrhage, or paramagnetic free radicals within phagocytosing macrophages heterogeneously 
distributed in the periphery of the abscess. The sine qua non of abscess: smooth ring enhancement of 
an abscess capsule on post gadolinium MR images is the most important part of distinguishing a non-
neoplastic from a neoplastic brain mass because nearly all enhancing brain lesions can present with 
ring enhancement. The abscess ring is most commonly very smooth, regular in thickness, and thin 
walled (approximately 5 mm in thickness), although it may be thinner along its medial margin, 
possibly due to variations in perfusion of gray and white mat-ter. Only infrequently, nodular or solid 
enhancement, incomplete thin rings, or thick and irregular rings may be observed, and these should 
provoke the consideration of other diagnoses. Daughter abscesses appear as adjacent smaller  
enhancing rings, often along the medial margin of the parent abscess, and can masquerade as a thick 
irregularity in the abscess wall at initial inspection. Abscesses tend to demonstrate high signal 
intensity on DWI, with a corresponding reduction in the apparent diffusion coefficient values. This is 
directly related to the cellularity and viscosity of the pus contained within an abscess cavity. 
 
                                
 
 
 
 
 
 
 
 
Fig: shows a T2 hyperintense lesion in the left occipital lobe with a hypointense wall, showing 
restriction of diffusion on the DWI image, s/o brain abscess. 
 
The MR spectroscopy pattern derived from the central portion of an abscess appears to be fairly 
characteristic. Thus, MRS seems to contribute to distinguishing an abscess from a necrotic brain 
tumor and a tuberculoma. The presence of the resonance of cytosolicAAsis considered as a sensitive 
marker of pyogenic brain abscess
63
. In an untreated abscess, resonances may be seen corresponding 
to acetate, lactate, alanine, succinate, and pyruvate, as well as a complex peak indicating amino acids 
valine, leucine, and isoleucine
7
. Acetate, lactate, succinate, 
 
 and pyruvate are metabolic end products arising from microorganisms. Acetate and succinate are not 
seen in association with necrotic tumors and are therefore fairly specific markers for pyogenic 
abscesses. However, these two resonances are not consistently identified in all abscess cavities. 
However, in vivo MRS does reveal an amino acid peak (valine, leucine, and isoleucine), which can be 
found in all abscesses but not in necrotic/cystic tumors. These amino acids arise from the proteolytic 
activity of neutrophils. In addition, the selective presence of Acetate with or without Succinate 
resonances on in vivo 
1
H-MR spectroscopy of abscesses has been described as a signature for 
anaerobic infection
63
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig shows a spectrum obtained from a brain abscess revealing a giant lactate peak, complex 
resonance seen between 1.9 to 2.4 ppm represent cytosolic amino acids, confirming that this is a 
pyogenic brain abscess. 
 
Cytomegalovirus (CMV) Encephalitis 
 
In adults, CMV infection is typically seen in AIDS patients and is uncommon in other 
immunocompromised patients. CMV more often presents outside the CNS, involving the respiratory 
tract, liver, gastrointestinal tract, genitourinary tract, or hematopoietic system. This virus exists in a 
latent form in most of the population, and nearly 90% of adults have antibodies to CMV. Reactivation 
usually results in a sub-clinical or mild infection, mimicking mononucleosis. In some 
immunodeficient patients, however, reactivation results in disseminated infection and/or severe 
necrotizing meningoencephalitis and ependymitis. CMV may involve the CNS and/or peripheral 
nervous system
17
. 
MR imaging depicts patchy and, less often, confluent periventricular white matter lesions with 
hypointense signal on T1 weighted images, as well as a hyperintense signal onT2-weighted images. 
Infrequently, subependymal enhancement is evident and, if present, is a valuable diagnostic clue. Fat 
suppressed MR with gadolinium may reveal a thickened enhancing choroid and retina in patients with 
CMV retinitis
7
. 
MR Spectroscopy, while not pathognomonic, may show reduction in the N-acetylaspartate relative to 
creatine and an increase in the choline peak, and the presence of a double peak of lactate/lipid
7
. 
 
 
 Stroke 
 
HIV patients have a small but definite increased incidence of stroke
64
. HIV infection can result in 
stroke via several mechanisms, including opportunistic infection, vasculopathy, cardioembolism, 
and coagulopathy
65
. HIV infection might predispose an individual to both arterial and venous 
thrombosis. However, the occurrence of stroke and HIV infection might often be coincidental. 
HIV associated vasculopathy describes various cerebrovascular changes, including stenosis and 
aneurysm formation, vasculitis, and accelerated atherosclerosis, and might be caused directly or 
indirectly by HIV infection, although the mechanisms are controversial. HIV and associated 
infections contribute to chronic inflammation. Highly active antiretroviral therapy is clearly 
beneficial in the management of patients with HIV infection, but impact the incidence of stroke in 
the HIV positive population in two important ways
65
. First, the drugs can be atherogenic and 
could increase stroke risk. Also, antiretroviral therapy can prolong life, increasing the size of the 
ageing population at risk of stroke. 
The MR features of ischemic arterial stroke are well known, consisting, earliest, of hyperintensity on 
DWI with low ADC coefficient in a characteristic vascular territory. Subsequently developing features 
are cortical swelling and loss of gray white borders, with hypointensity on T1 weighted and 
hyperintensity on T2 weighted sequences. GRE (T2*) sequences are useful to detect foci of 
haemorrhage
10
. 
Venous sinus thrombosis manifests as loss of the normal flow void of the dural venous sinus. The 
thrombus in the sinus is initially isointense and hypointense on T1 weighted and T2 weighted 
sequences respectively and then grows to be hyperintense on both T1 and T2 weighted sequences. If a 
venous infarct occurs it appears hypointense on T1 and of mixed intensity on T2 weighted images, 
with mass effect due to extensive edema. Foci of haemorrhage are often present, readily detectable on 
GRE (T2*) sequences
10
. 
Metabolic abnorrmalities detected by MRS (reduced phosphocreatine and ATP, increased inorganic 
phosphate, elevated lactate, and acidosis) in ischemic brain due to arterial or venous thrombosis may 
precede structural alterations detected by any form of neuroimaging
66
. The characteristic feature is 
held to be Elevated lactate and decreased NAA
10
. An increase in tissue Lac production is seen with 
anaerobic metabolism and is detectable at a cerebral blood flow threshold just above that for tissue at 
risk of infarction
67
. Animal studies have suggested that Lac is detectable within minutes of stroke and 
that NAA may decrease by as much as 20% in the first hour and 50% in the first 6 hours. MRS may 
also help to refine penumbral definition by PWI–DWI mismatch. It has previously been hypothesized 
that preserved NAA but detectable Lac may represent the MRS penumbral signature. MRS may 
therefore be a reliable tool for the investigation of the pathophysiology of stroke
67
. 
 METHOD AND MATERIALS 
 
STUDY DESIGN – Prospective observational study design. 
 
The study was carried out for a period of 8 months in the Department of Radiology, Seth G.S. Medical 
College and K.E.M. Hospital, Parel, Mumbai with the approval of the Institutional Ethics Committee, 
IEC. Any HIV positive patients with neurologic disease referred for MRI examination on outpatients 
or inpatient basis was taken up for the study with the informed consent of the patient or guardian. 
Those patients, who came to MRI for an unrelated pathology, were taken up as controls after taking 
consent from the patient. 
 
INCLUSION CRITERIA 
 
 Patients who are HIV positive (by ELISA test) and are referred for MRI examination for 
neurologic disease.   
 Patients able to cooperate for the examination e.g., ability to lie immobile for the period of the 
examination.  
 
EXCLUSION CRITERIA 
 
Patient having absolute or relative contraindications for contrast enhanced MRI examination such as 
cardiac pacemaker, metallic (MRI non compatible) implants, or with kidney dysfunction (serum 
creatinine > 2mg/dl) etc.  
 Patients who are unable to cooperate for the procedure.  
 Patients or guardians who refused consent for the procedure. 
Those patients who come to MRI for unrelated pathology were taken up as controls. 
 
 STUDY PROCEDURE 
 
36 consecutive HIV positive patients were examined by MRI and subsequently followed up for 
establishment of clinical diagnosis. The magnetic resonance imaging studies were conducted on 
Sonata Maestro class Magnetom 1.5 T MR Scanner from Siemens (Erlanger, Germany) with gradient 
field strength of 40mT/m
2
. A dedicated head coil was used. Unconscious patients, or patients with 
altered consciousness who came for the MRI scan were accompanied by a physician who pronounced 
the patients fit to undergo the scan, and was present during the study to monitor the patient. 
Occasionally sedation was required, administered by the accompanying physician. 
Those patients who came for MRI for pathologies or symptoms unrelated to CNS, or with 
demonstrable normal scans were taken as controls. Proper informed consents were taken from the 
patients or their representatives as well as from the controls. 
  
Standard protocol for brain MRI was - 
 
 Acquiring the localizer.  
 T2 tirm cor 3mm images.  
 T2 TSE 3mm axial images.  
 Gradient sequence  
 T1 TSE sagittal 3mm images.  
 Diffusion weighted imaging.  
 Post Contrast T1 TSE coronal and axial 3mm images  
 Multivoxel MR spectroscopy with short TE (TE=35ms) 
 
Protocol was adjusted according to patient‘s requirement. Patients were followed up for final clinical 
diagnosis. 
MR spectroscopy findings in any focal lesion detected in all cases were analysed and described 
ordering by the pathology the patients presented with and correlating with the final clinical diagnosis. 
In all patients, the NAA/Cr ratio of the background white matter was recorded. Both cases and 
controls were distributed into two age groups: Patients below 40 years or equal to 40 years (Group 1) 
and patients greater than 40 years of age (Group 2). The NAA/Cr ratio was compared to that of the 
Age and Gender matched controls by means of statistical analysis. 
 
END POINT 
 
 To analyze the role of MR Spectroscopy as an important part of the MRI protocol in the diagnosis 
of HIV associated CNS disease.  
 To compare the NAA/Cr ratio values of HIV positive patients and patients without HIV infection. 
 
OUTCOME MEASURES AND STATISTICAL ANALYSIS 
 
Analyzing the spectroscopy findings of patients, and comparing values of NAA/Cr ratio of cases with 
controls. 
 
RESULTS 
 
Plain and contrast MRI and MR Spectroscopy was done in 35 patients in this study. Patients from a 
wide range of age groups were included in the study and were divided into two groups: The first, with 
age less than or equal to 40 years comprised of 19 patients and the second with age more than 40 
years comprised 16 patients. Amongst our patients, 24 were male and 11 were female. 
Out of our 35 cases of CNS Disease in HIV positive patients, 8 patients had no identifiable focal or 
diffuse brain lesion. Out of the 27 patients who had identifiable lesions in the brain, 22 patients had 
infective disorders, 4 had vascular disease and 1 had neoplastic disease. The distribution of specific 
disorders was as follows: 6 had PML, 9 had CNS tuberculosis, 4 had toxoplasmosis, 2 had HIV 
encephalopathy, 2 had arterial territory infarcts, 2 had venous sinus thrombosis, 2 had cryptococcosis, 
1 had meningioma, 1 had a brain abscess, and in 7 patients no focal lesions could be identified. One of 
these patients had both HIV Encephalopathy and Toxoplasmosis. 
 
Spectroscopy results – 
In controls, sequences of multivoxel spectroscopy with a TE of 30 ms were taken, at the level of 
centrum semiovale covering the subcortical white matter. In patients, sequences of multivoxel 
spectroscopy with a TE of 30 ms were taken covering the lesion and the adjacent white matter. 
Spectroscopic data were sampled from voxels within the lesions as well as from within the normal 
appearing white matter. The spectra from the white matter in cases and normal appearing white matter 
in controls were analyzed to obtain the NAA/Cr Ratio. 
 
DISCUSSION OF DATA 
 
The data at hand is continuous in nature. The sample size of NAA/Cr Ratio for Cases is 36 and that of 
NAA/Cr Ratio for Controls is 15. We have further divided the data in two categories, namely, (1) for 
people below (or equal) age 40 and (2) for people above age 40. All the tests which will be conducted 
here will have 95% level of significance. 
 
TEST FOR RANDOMNESS 
 
Any statistical analysis depends on the assumption that the data is necessarily random in nature. So we 
will now check for the randomness of the data by runs test (also called Wald–Wolfowitz test). This 
test will be conducted on NAA/Cr Ratio for Cases and NAA/Cr Ratio for Controls‘. In both the tests 
our null hypothesis is that the data is random against the data is not random. 
On applying the Runs test for NAA/Cr Ratio for Cases  
p-value = 0.635  
On applying the Runs test for NAA/Cr Ratio for Controls  
p-value = 0.430  
In both the cases as the p-values are greater than 0.05, we can conclude that the null hypothesis is true 
and hence the data is random. 
 TEST FOR NORMALITY 
 
Now we have 3 pairs of data at hand. We will now test whether the data follow normal distribution 
(Gaussian). This test is very important as depending on the result, our test procedures will vary. We 
will use Anderson-Darling Test of Normality in all the 6 cases. 6 test for normality plots (Probability 
Plots) will be given below, each having the p-values given on those plots. 

From the graphs it can be shown that all of them have p-value much greater than 0.05 and hence it can 
be concluded that the data follow Gaussian distribution. 
 
SUMMARY AND DESCRIPTIVE STATISTICS 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TESTING OF HYPOTHESES 
 
As we have 3 pairs of data, we will conduct three separate tests of mean of the ratio 
 
 NAA/Cr Ratio for Cases vs. NAA/Cr Ratio for Controls  
 NAA/Cr Ratio for Cases (<=40) vs. NAA/Cr Ratio for Controls(<=40)  
 NAA/Cr Ratio for Cases (>40) vs. NAA/Cr Ratio for Controls  (>40)  
 
In all the cases, we will use ‗Two sample Welch‘s t-test as the data follows normality and the 
population variance is not known (which will be approximated by the sample variance in all the 
cases). We don‘t assume that the two populations under each test have homoscedasticity (or equal 
variance).  
 
1. NAA/Cr Ratio for Cases vs. NAA/Cr Ratio for Controls  
Our null hypothesis is mean of NAA/Cr Ratio for Cases and mean of NAA/Cr Ratio for Controls is 
equal against mean of NAA/Cr Ratio for Cases is lesser than mean of NAA/Cr Ratio for Controls 
 
Two-sample Welch’s t test for NAA/Cr Ratio for Cases vs. NAA/Cr Ratio for Controls 
 
 
 N Mean St Dev SE 
    Mean 
     
NAA/Cr Ratio for Cases (<=40) 35 1.623 0.423 0.071 
     
NAA/Cr Ratio for Controls(<=40) 15 1.986 0.293 0.076 
     
 
t-Value = -3.49 (value of the statistic), p-Value = 0.001 
Here the p-value is lesser than 0.05, so we reject the null hypothesis. Hence we conclude that NAA/Cr 
Ratio for Cases is significantly lesser than NAA/Cr Ratio for Controls. (Level of significance is set at 
95%) 
 
2. NAA/Cr Ratio for Cases (Age </=40) vs. NAA/Cr Ratio for Controls (Age </=40) 
 
Our null hypothesis is mean of NAA/Cr Ratio for Cases (<=40) and mean of NAA/Cr Ratio for 
Controls (<=40) is equal against mean of NAA/Cr Ratio for Cases (<=40) is lesser than mean of 
NAA/Cr Ratio for Controls (<=40) 
 
Two-sample Welch’s t test for NAA/Cr Ratio for Cases (Age </=40) vs. NAA/Cr Ratio for 
Controls (Age </=40) 
 
 N Mean St Dev SE 
    Mean 
     
NAA/Cr Ratio for Cases (<=40) 19 1.669 0.374 0.086 
     
NAA/Cr Ratio for Controls(<=40) 7 2.120 0.221 0.084 
     
 
t-Value = -3.76, p-Value = 0.001     
     
     
Here the p-value is lesser than 0.05, so we reject the null hypothesis. Hence we conclude that NAA/Cr 
Ratio for Cases (<=40) is significantly lesser than NAA/Cr Ratio for Controls. (Level of significance 
is set at 95%). 
 
3. NAA/Cr Ratio for Cases (Age >40) vs. NAA/Cr Ratio for Controls (Age >40)  
 
Our null hypothesis is mean of NAA/Cr Ratio for Cases (>40) and mean of NAA/Cr Ratio for 
Controls (>40) is equal against mean of NAA/Cr Ratio for Cases (>40) is lesser than mean of NAA/Cr 
Ratio for Controls (>40) 
 
Two-sample Welch’s t test for NAA/Cr Ratio for Cases (Age >40) vs. NAA/Cr Ratio for 
Controls (Age >40) 
 
     
 N Mean St Dev SE 
    Mean 
     
NAA/Cr Ratio for Cases (<=40) 16 1.567 0.481 0.12 
     
NAA/Cr Ratio for Controls(<=40) 8 1.869 0.310 0.11 
     
 
t-Value = -1.86, p-Value = 0.039 
 
Here the p-value is lesser than 0.05, so we reject the null hypothesis. Hence we conclude that NAA/Cr 
Ratio for Cases (>40) is significantly lesser NAA/Cr Ratio for Controls (>40). (Level of significance 
is set at 95%). 
 
BOX-PLOT (BOX-WHISKER DIAGRAM) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
The specific parameters for PML were also tabulated. 
 
 
Number Age Sex Diagnosis NAA/Cr Ratio Cho/Cr mI/Cr 
 (years)      
       
1 9 M PML 1.94 0.7 0.24 
       
2 40 M PML 1.43 0.92 0.11 
       
3 42 F PML 1.1 0.88 0.1 
       
4 44 M PML 1.54 0.67 0.32 
       
5 46 M PML 1.63 0.9 0.16 
       
6 55 M PML 0.92 1.03 0.02 
       

  
DISCUSSION 
 
MRI is undoubtedly the finest imaging modality for the evaluation of CNS disease in HIV and MR 
Spectroscopy has an important ancillary role in the establishment of the diagnosis. There have been 
multiple studies involving the distribution of CNS disease in HIV. HIV encephalopathy (AIDS 
Dementia complex) is commonly held to be the most frequent neurologic disease in the HIV positive 
population
7
. However unequivocal imaging evidence of HIV encephalopathy was found in only 2 of 
our patients (22%).Collazos found the most frequent CNS infections to be Toxoplasmosis, PML, 
Cryptococcosis and CMV infection
68
. A large study in Africa by Luma et al found Toxoplasmosis 
followed by cryptococcal infection to be the most common, and tuberculosis was also common
69
. In 
the East, in a large series in Thailand,Kongsiriwattanakul et al found that Cryptococcal infection was 
the most common infection, followed by tuberculosis
70
, and in Korea Choe et al found PML and 
Tuberculosis to be the most common
71
. A recent Indian autopsy study by Lanjewar et al found 
Toxplasmosis to be the most common, with CNS Tuberculosis being almost as commonly found
72
. In 
our study, 25 patients (81%) were found to have neuroinfection, with the commonest being CNS 
Tuberculosis (9 patients, 24%), followed by PML (6 patients, 16%). Toxoplasmosis was the third 
most common seen in 4 patients (11%). Neuroinfection with tuberculosis takes various forms. In our 
study, 8 out of 9 (89%) patients were referred for MRI for tuberculous meningitis and one 
asymptomatic patient for follow up in a case of tuberculoma. 2 of the patients had vascultic infarcts 
(22%) and active tuberculomas were demonstrated in 2 (22%). No spinal tuberculous lesion was 
found in our study. MR spectroscopy is not of great significance in tuberculous meningitis; however 
spectra obtained from the tuberculomas revealed reduced NAA with a prominent lipid – lactate peak. 
PML was the second most common pathology found in our study. PML is characterised 
spectroscopically by reduced NAA, increased choline and increased myoinositol. The NAA/Cr ratio is 
reduced in PML further than that due to the decrease caused by other pathologies in HIV positive 
population
73
. This was consistent with the values obtained in our study, where the mean NAA/Cr 
ratio for all HIV patients in our study was found to be 1.6226 with a standard deviation of 0.4229 and 
in cases of patients with PML, the NAA/Cr ratio 1.4267 with a standard deviation of 0.3691. The 
raised choline peak was also found in the spectra of all our patients (Mean Cho/Cr value 0.85). 
Toxoplasmosis was the third most common neuroinfection in our study. While toxoplasmosis has 
characteristic imaging findings on MRI study, it is occasionally difficult to differentiate them from 
PCNSL. The characteristic finding of a highly elevated lipid lactate peak on toxoplasmosis helps to 
stamp the lesion in question as toxoplasma. In all four of our toxoplasmosis patients, a prominent lipid 
lactate peak was visualised. Out of our 36 patients, only two had imaging findings consistent with 
HIV encephalopathy. However, conventional MRI is found to not be sensitive to brain changes in 
early HIV Encephalopathy
74
. MR spectroscopy is sensitive in that regard. NAA is considered the 
marker for viable neurons
73
. The NAA/Cr ratio in HIV Positive population is 1.6266 for all cases, 
1.6695 for patients equal to or less than 40 years of age, and 1.5669 for patients more than 40 years of 
age. The respective values for HIV negative control group are 1.9860, 2.12 and 1.8788. On comparing 
the mean value of NAA/Cr to that of the normal controls we find there is a definite reduction in the 
value in both the age groups. In our study, spectra obtained bear this out with a reduction in the NAA 
peak seen in one patient, but a normal NAA peak seen in one patient. An increase in Cho/Cr has also 
been reported to occur in HIV encephalopathy with clear imaging findings, which was also seen in 
one patient. Though the number of patients is low our findings of diagnostic accuracy of 50% is in 
line with that of published studies
73
. Though most studies have concentrated on the utility of NAA/Cr 
in diagnosis of HIV Encephalopathy, Arneth et al found that mI/Cr is the parameter that shows 
earliest change in HIV encephalopathy
43
. High field (3T) MR Spectroscopy can resolve other 
metabolites like Glu (Glutamate) and Gln (Glutamine) which have also been found to reduce in HIV 
encephalopathy
75
. 
 
 
 
Cryptococcosis 
 
Only 2 of our patients (5.6%) presented with cryptococcosis. The common finding of reduced NAA is 
seen in the spectrum in the form of reduced NAA peaks as well as moderately raised choline peaks in 
both the patients. This pattern signifies Trehalose peaks were not identified. Trehalose has been found 
in vitro studies and experimental studies
7,47
 and definitive studies regarding its distribution detectable 
by in vivo spectroscopy were not found after an exhaustive search of the available literature. 
 
 
Stroke 
 
Imaging findings in stroke correlate with spectroscopic findings of reduced NAA and mild increase in 
lactate
10
. We had two patient of arterial thrombosis (5.6%) and two patients of dural sinus thrombosis 
(5.6%). The patients with arterial thrombosis showed a mild reduction in NAA but no significant 
lactate peak. Pereira et al have found that MR Spectroscopy in acute stroke may serve a prognostic 
purpose
76
. In patients with a lower infarct volume, a lower initial NAA concentration was associated 
with worse prognosis. This however did not hold in case of large infarct volume which was 
independently associated with worse prognosis. There were no parenchymal changes in the patients 
with dural venous sinus thrombosis in our study. No spectroscopic anomalies were detectable. No 
definitive study on the efficacy of MR Spectra in Venous sinus thrombosis was found after an 
exhaustive search of the available literature, although MR Spectroscopy may be used to differentiate a 
venous infarct from a tumour if the imaging appearance is equivocal
10
. In our study we did not have 
any patients of PCNSL or CMV encephalitis. A single patient of meningioma was included as he was 
incidentally found to be HIV positive. 
Also at the time of writing, no published spectroscopy data on normal Indian population was found. 
The sample size for HIV negative population was small (15) but it gives an idea of the normal MR 
Spectroscopic findings and normal value of NAA/Cr. 
 
 
SUMMARY 
 
The study was carried out in the Department of Radiology, KEM Hospital. A total of 50 patients were 
enrolled in the study, and MRI brain with MR spectroscopy was done. Out of these, 35 were HIV 
positive patients (cases). 15 patients with HIV negative status who also underwent MRI for unrelated 
pathologies were enrolled as controls. They also underwent MRI brain with MR spectroscopy. The 
study was done on a 1.5T Siemens Sonata Magnetom MRI Scanner. 
All patients and cases underwent conventional imaging sequences (T1W, T2W, T2 FLAIR and Post 
contrast T1W) and Diffusion weighted imaging (DWI). Multivoxel MR Spectroscopy (MRS) with 
short TE (30msec) was done to determine their NAA/Cr ratio and the value from HIV positive 
patients was compared with data from 15 controls. 
The MRI Imaging findings were reviewed and the diagnosis confirmed on clinical basis with the help 
of the attending physician. 
Tuberculosis was the most common neurologic disease found in the HIV positive group, consisting of 
9 patients. Two patients had healed granulomas. Seven of these patients had tuberculous meningitis 
amongst which a further 2 had vasculitic infarcts. Another two in this group had tuberculomas. 
Prominent lipid lactate peaks on the spectra obtained from the lesions confirmed the diagnosis of 
tuberculoma. PML was seen in 6 patients. NAA/Cr was found to be reduced in all the patients, and in 
fact the value was further reduced compared to the HIV positive group as a whole. Raised choline and 
myoInositol peaks were also found in all the patients. 
Toxoplasmosis was seen in 4 patients. MR Spectroscopy showed lipid – lactate peaks confirming the 
diagnosis. A single patient with brain abscess was seen where also the spectroscopic data from the 
lesion confirmed the diagnosis with a lactate peak as well as amino acid resonances at characteristic 
locations. 2 patients had HIV encephalopathy on the imaging study. Their spectra also revealed 
lowered NAA peaks along with raised choline peaks.2 patients with cryptococcosis showed 
characteristic imaging finding of enlarged Virchow Robin (perivascular) spaces. They revealed 
elevated choline peaks in addition to reduced NAA. No trehalose peaks were identified. MR 
Spectroscopy was also done in 4 patients of vascular thrombosis, two arterial and two venous, where 
the MR Spectroscopic findings were not specific. 
In 7 patients no focal lesions could be identified on conventional MRI sequences however on MR 
spectroscopic analysis NAA was found to be reduced in comparison to the controls. 
The values of NAA/Cr were determined after duly processing the spectroscopic data from both cases 
and controls. Each group (Cases and controls) were divided on the basis of age into two age groups: 
Lesser than or equal to 40 years, and greater than 40 years. In all three groups the values of the mean 
NAA/Cr ratio was significantly reduced in comparison to controls. An ancillary finding was the 
reduction of NAA/Cr further in cases of PML. 
Combined use of both the conventional and advanced MRI sequences is advisable as spectroscopy 
helps in confirming the diagnosis of opportunistic infection of the CNS in HIV positive patients. 
NAA/Cr ratio is reduced in HIV positive patients and is a marker for HIV infection of the brain even 
in the absence of imaging findings of HIV encephalopathy or when the patient is symptomatic due to 
neurologic disease of other etiologies. 
 
 
CONCLUSION 
 
MRI is the optimum modality in the imaging of the brain in HIV positive patients with neurologic 
disease. There are a wide number of possibilities in the evaluation of HIV positive patients with 
neurologic disease MRI helps in early diagnosis thus helping to establish appropriate treatment. 
MRI is excellent at establishing the specific disease etiology. However in specific clinical situations, 
MR Spectroscopy acts as a confirmatory or problem solving sequence. In the differentiation of 
toxoplasmosis and lymphoma, or tumor and tuberculoma, or tuberculous and pyogenic abscess, the 
assistance of MR Spectroscopy is required. 
The use of MR Spectroscopy in establishing the diagnosis of HIV Encephalopathy in all infected 
patients is also elucidated. As HIV is a neurotropic virus, it affects the brain much earlier than when 
imaging manifestations develop. The use of MR Spectroscopy as an additional sequence in the routine 
evaluation of HIV patients is advisable, especially as studies have suggested that effective 
antiretroviral therapy may reverse the spectral changes
35
 in early HIV Encephalopathy. 
Conventional and advanced sequences play a complimentary role. Both need to be studied in 
conjunction. Use of both conventional and advanced MRI sequences is advisable to achieve a high 
degree of accuracy in making a complete diagnoses that is unmatched by any other investigative tool. 
Also MR Spectroscopy may be able to detect the onset of HIV Encephalopathy at an earlier time than 
conventional MRI sequences. 
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ANNEXURE 
 
 
 
ANNEXURE – A : ABBREVIATIONS 
 
 
 
CT- Computed Tomography 
 
MRI - Magnetic Resonance Imaging 
 
MRS –    Magnetic    Resonance  
Spectroscopy 
 
NMR – Nuclear Magnetic Resonance 
 
SVS – Single Voxel Spectroscopy 
 
CSI – Chemical Shift Imaging 
 
SNR – Signal to noise Ratio 
 
MTR – Magnetization transfer ratio 
 
TE - Time to Echo 
 
TR- Time to Repeat 
 
T1W- T1 Weighted 
 
T2WI- T2 Weighted 
 
GRE- Gradient Recalled Echo 
 
FLAIR  –Fluid  Attenuated  Inversion  
Recovery 
 
DWI – Diffusion Weighted Imaging 
 
PWI – Perfusion Weighted Imaging 
 
SWI – Susceptibility Weighted Imaging 
 
1
H - Proton 
 
NAA - N-acetylaspartate 
 
Cho – Choline 
 
 
 
 
 
 
 
 
Cr – Creatine and phosphocreatine 
 
Lac – Lactate 
 
Glx – Glutamate and Glutamine 
 
Gln – Glutamine 
 
mI – Myoinositol 
 
HIV – Human Immunodeficiency Virus 
 
AIDS:   Acquired   Immunodeficiency  
Syndrome 
 
IRIS - Immune reconstitution 
inflammatory syndrome 
 
PML- Progressive Multifocal  
Leukoencephalopathy 
 
CVD – Cerebrovascular Disease 
 
PCNSL – Primary Central Nervous 
system Lymphoma 
 
CMV - Cytomegalovirus 
 
TBM – Tuberculous meningitis 
 
SSS – Superior sagittal sinus 
 
MCA - Middle cerebral artery 
 
CNS – Central Nervous system 
 
HAART - Highly active antiretroviral 
therapy 
 
ART - Antiretroviral therapy 
  
ANNEXURE – C : CASE RECORD FORM 
 
 
 
Name:  Date: 
Age:   
Sex : Male/Female  
Indoor patient number: Outdoor patient number: 
Date of Examination  
Number:  
Referring physician  
Weight of the patient:  
Chief complaints Duration of symptoms : 
Any other complaints:  
Past H/O:  
Relevant neurological examination findings:  
Current CD4 count (for HIV positive patients only):  
MR Spectroscopy Findings:  
i) NAA/Cr Ratio:  
ii) Analysis Of Spectroscopy Curve:  
 
 
Final diagnosis: 
 
 
 
 
 
 
Signature of the Chief Investigator 
 
